OXYVIST
Live / Allowed — Second extension granted (statement of use) (as of 22 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98646705
- Mark type
- Word mark
- Filed
- 12 Jul 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Contrast media for in vivo imaging; Contrast media for in-vivo imaging; Contrast media for use with imaging medical equipment
Owner
- Surgisense Corporation, Bethesda, MD, US
- Surgisense Corporation, Bethesda, MD, US
Prosecution history
- 23 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2026 — SOU EXTENSION 2 GRANTED
- 22 May 2026 — SOU EXTENSION 2 FILED
- 22 May 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 1 GRANTED
- 25 Nov 2025 — SOU EXTENSION 1 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED